🇺🇸 FDA
Patent

US 8026263

Methods for inhibiting neoproliferative changes in blood vessel walls

granted A61KA61K31/415A61P

Quick answer

US patent 8026263 (Methods for inhibiting neoproliferative changes in blood vessel walls) held by The Regents of the University of California expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/415, A61P, A61P9/00, A61P9/10